Skip to Content
Merck
CN
Histone Lysine Demethylase Inhibitor VIII, GSK-J4 Histone Lysine Demethylase Inhibitor VIII, GSK-J4, CAS 1373423-53-0, is converted to GSK-J1 intracellularly for effective JMJD3 and UTX inhibition (~ 25 to 50 µM in HeLa cultures).

GSK-J4

Histone Lysine Demethylase Inhibitor VIII, GSK-J4 Histone Lysine Demethylase Inhibitor VIII, GSK-J4, CAS 1373423-53-0, is converted to GSK-J1 intracellularly for effective JMJD3 and UTX inhibition (~ 25 to 50 µM in HeLa cultures).
Synonym(s):
Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate, Histone Lysine Demethylase Inhibitor VIII, GSK-J4
Empirical Formula (Hill Notation):
C24H27N5O2
CAS Number:
Molecular Weight:
417.50

Products

Product Category
Brand
Color
Formula Weight
Physical Form
Purity
Research Area
Quality Segment